X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2304) 2304
Publication (266) 266
Book Review (67) 67
Book Chapter (17) 17
Dissertation (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pegylated liposomal doxorubicin (1771) 1771
humans (1568) 1568
index medicus (1342) 1342
oncology (1064) 1064
female (912) 912
chemotherapy (757) 757
cancer (647) 647
pharmacology & pharmacy (565) 565
middle aged (463) 463
animals (455) 455
ovarian cancer (445) 445
aged (431) 431
ovarian neoplasms - drug therapy (388) 388
doxorubicin - administration & dosage (383) 383
antineoplastic combined chemotherapy protocols - therapeutic use (380) 380
antineoplastic agents - therapeutic use (361) 361
adult (352) 352
doxorubicin (347) 347
anthracyclines (327) 327
doxorubicin - analogs & derivatives (320) 320
treatment outcome (320) 320
nanoparticles (291) 291
drug delivery systems (290) 290
care and treatment (284) 284
paclitaxel (280) 280
male (278) 278
liposomes (260) 260
phase-ii trial (232) 232
pegylated-liposomal doxorubicin (231) 231
polyethylene glycols - administration & dosage (226) 226
therapy (223) 223
carcinoma (220) 220
doxorubicin - adverse effects (220) 220
neoplasms - drug therapy (216) 216
antineoplastic agents - administration & dosage (213) 213
trial (208) 208
doxorubicin - therapeutic use (206) 206
research (205) 205
drugs (195) 195
pharmacokinetics (193) 193
obstetrics & gynecology (189) 189
drug therapy (188) 188
phase-ii (185) 185
mice (182) 182
toxicity (178) 178
antineoplastic combined chemotherapy protocols - adverse effects (176) 176
disease-free survival (176) 176
hematology, oncology and palliative medicine (176) 176
phase-iii trial (176) 176
breast cancer (174) 174
hematology (171) 171
neoplasm recurrence, local - drug therapy (169) 169
health aspects (167) 167
breast neoplasms - drug therapy (165) 165
ovarian neoplasms - pathology (162) 162
drug-delivery (161) 161
aged, 80 and over (159) 159
analysis (158) 158
tumors (158) 158
antineoplastic agents - adverse effects (155) 155
article (154) 154
drug resistance, neoplasm (154) 154
breast-cancer (150) 150
cell line, tumor (150) 150
polyethylene glycols - adverse effects (150) 150
randomized phase-iii (148) 148
drug delivery (146) 146
solid tumors (146) 146
medicine & public health (141) 141
nanoscience & nanotechnology (141) 141
multiple myeloma (140) 140
vehicles (140) 140
carboplatin (139) 139
bortezomib (138) 138
chemistry, multidisciplinary (138) 138
metastatic breast-cancer (136) 136
in-vivo (135) 135
antitumor-activity (130) 130
cisplatin (129) 129
gynecologic-oncology-group (128) 128
multiple myeloma - drug therapy (126) 126
antibiotics, antineoplastic - administration & dosage (124) 124
clinical trials (124) 124
cardiotoxicity (121) 121
nanotechnology (121) 121
antineoplastic agents - pharmacology (120) 120
gemcitabine (120) 120
neoplasm staging (115) 115
nanomedicine (114) 114
pegylated liposomes (114) 114
polyethylene glycols - therapeutic use (113) 113
combination (112) 112
cancer therapies (111) 111
topotecan (110) 110
breast neoplasms - pathology (106) 106
drug administration schedule (106) 106
stem-cell transplantation (103) 103
antineoplastic combined chemotherapy protocols - administration & dosage (102) 102
retrospective studies (102) 102
review (102) 102
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2263) 2263
French (15) 15
German (14) 14
Polish (13) 13
Spanish (8) 8
Japanese (5) 5
Russian (3) 3
Hungarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 2011, Volume 71, Issue 18, pp. 2531 - 2558
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 10/2019, Volume 30, Issue 9, pp. 948 - 952
Pegylated liposomal doxorubicin (Peg-Dox) treatment resulted in a good outcome for patients with lymphoma and multiple myeloma, with reduced cardiotoxicity and... 
pegylated liposomal doxorubicin | Clinical Reports | chemotherapy | myeloid neoplasm
Journal Article
Cancer, ISSN 0008-543X, 08/2010, Volume 116, Issue 16, pp. 3969 - 3977
Journal Article
Cancer, ISSN 0008-543X, 02/2006, Volume 106, Issue 4, pp. 848 - 858
BACKGROUND. Pegylated liposomal doxorubicin has pharmacologic and safety advantages over conventional doxorubicin. METHODS. For this noninteriority trial, 192... 
Dexamethasone | Neutropenic fever | Drug toxicity | Multiple myeloma | Liposomes | Drug resistance | Doxorubicin | Pegylated liposomal doxorubicin | Vincristine | Neoplasms | dexamethasone | 1ST-LINE TREATMENT | multiple myeloma | vincristine | ONCOLOGY-GROUP | liposomes | COMBINATION THERAPY | neutropenic fever | CONVENTIONAL DOXORUBICIN | TRANSPLANTATION | pegylated liposomal doxorubicin | THALIDOMIDE PLUS DEXAMETHASONE | KAPOSIS-SARCOMA | ONCOLOGY | drug toxicity | REDUCED-DOSE DEXAMETHASONE | VAD | doxorubicin | drug resistance | neoplasms | DVD-T | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Polyethylene Glycols - adverse effects | Male | Fever - chemically induced | Multiple Myeloma - drug therapy | Doxorubicin - analogs & derivatives | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Administration, Oral | Catheterization, Central Venous | Treatment Outcome | Polyethylene Glycols - administration & dosage | Multiple Myeloma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Infusions, Intravenous | Doxorubicin - adverse effects | Pharmaceutical research | Drugs | Myelocytic leukemia | Reports | Nonlymphoid leukemia | Research | Drug therapy, Combination | Drug therapy | Health aspects
Journal Article
Annals of Oncology, ISSN 0923-7534, 2011, Volume 22, Issue 1, pp. 39 - 48
Journal Article
Journal Article
BBA - General Subjects, ISSN 0304-4165, 01/2016, Volume 1860, Issue 1, pp. 108 - 119
Among nanodrugs, PEGylated nanoliposomes loaded with an active agent are of major importance. In this paper we studied the structures and morphology of... 
Liposomal doxorubicin | Generic drugs | Drug delivery | PEGylated liposomes | WAXS | SAXS | STERICALLY STABILIZED LIPOSOMES | BIOCHEMISTRY & MOLECULAR BIOLOGY | SIZE | MEMBRANES | VASCULAR-PERMEABILITY | DELIVERY | MACROMOLECULAR THERAPEUTICS | BIOPHYSICS | TEMPERATURE | CONFINEMENT | LAYER | EFFICIENT | Anthracyclines
Journal Article
Journal Article
ANNALS OF ONCOLOGY, ISSN 0923-7534, 03/2004, Volume 15, Issue 3, pp. 440 - 449
Background: This study was designed to demonstrate that efficacy [progression-free survival (PFS)] of CAELYX(TM) [pegylated liposomal doxorubicin HCl (PLD)] is... 
MULTICENTER TRIAL | cardiotoxicity | EPIRUBICIN | THERAPY | pegylated liposomal doxorubicin | ONCOLOGY | ENCAPSULATED DOXORUBICIN | COMBINATION | CARCINOMA | CHEMOTHERAPY
Journal Article
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 07/2019, Volume 30, Issue 6, pp. 636 - 639
Four ovarian cancer patients with severe plantar palmar erythrodysesthesia or mucositis precluding further therapy from pegylated liposomal doxorubicin on the... 
pegylated liposomal doxorubicin | ONCOLOGY | ovarian cancer | cutaneous toxicity | MULTICENTER PHASE-II | RELAPSED OVARIAN-CANCER | PHARMACOLOGY & PHARMACY | CARCINOMA | alternative schedule of drug administration | Medical research | Stomatitis | Medicine, Experimental | Dosage and administration | Genetic aspects | Research | Drug therapy | Doxorubicin | Ovarian cancer
Journal Article